Revolution (RVMD) PT Raised to $122 at JPMorgan
Tweet
Share
E-mailGet Alerts RVMD Hot Sheet
Price: $155.99 +3.09%
Rating Summary:
22 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
22 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
JPMorgan analyst Brian Cheng raised the price target on Revolution (NASDAQ: RVMD) to $122.00 (from $92.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
- Abivax (ABVX) PT Lowered to $136 at Wolfe Research
- Revolution Medicines (RVMD) call put ratio 3.3 calls to 1 put after presented the full results from the Phase 3 RASolute 302 trial evaluating daraxonrasib at ASCO
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
